Ewing Sarcoma — Trials

Ewing Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 76
Recruiting: 41
Ph III recruiting: 1
Growth YoY: —
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 1–19 of 19 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06395103	Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)	recruiting	Phase 1 / Phase 2	90	Merck Sharp & Dohme LLCINDUSTRY	23	Sep 17, 2026	clinicaltrials
NCT06465199	Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas	recruiting	Phase 1 / Phase 2	265	Milton S. Hershey Medical CenterOTHER	1	Sep 3, 2026	clinicaltrials